Sequential enfortumab vedotin (EV) after platinum-based chemotherapy in metastatic or locally advanced urothelial cancer: Complete response, bladder preservation and survival.

被引：0
|
作者：
Cen, Putao
Chan, Kok Hoe
Canfield, Steven
Shu, Tung
Maithel, Neha
Tammisetti, Varaha
机构：
[1] Univ Texas Hlth Sci Ctr Houston UTHealth Houston, McGovern Med Sch, Houston, TX USA
[2] Univ Texas Med Sch Houston, Houston, TX USA
[3] Univ Texas Hlth Sci Ctr Houston, Houston, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
529
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Efficacy of Tegafur-Uracil in Advanced Urothelial Cancer Patients after the Treatment Failure of Platinum-based Chemotherapy
    Maolake, Aerken
    Izumi, Kouji
    Takahashi, Rie
    Itai, Shingo
    Machioka, Kazuaki
    Yaegashi, Hiroshi
    Nohara, Takahiro
    Kitagawa, Yasuhide
    Kadono, Yoshifumi
    Konaka, Hiroyuki
    Mizokami, Atsushi
    Namiki, Mikio
    ANTICANCER RESEARCH, 2015, 35 (03) : 1603 - 1606
  • [42] Enfortumab vedotin (EV) in combination with pembrolizumab (P) versus chemotherapy in previously untreated locally advanced metastatic urothelial carcinoma (la/mUC): Subgroup analyses results from EV-302, a phase 3 global study
    Van Der Heijden, Michiel Simon
    Powles, Thomas
    Gupta, Shilpa
    Bedke, Jens
    Kikuchi, Eiji
    De Wit, Ronald
    Galsky, Matt D.
    Duran, Ignacio
    Necchi, Andrea
    Retz, Margitta
    Yu, Evan Y.
    Hoffman-Censits, Jean H.
    Iyer, Gopa
    Park, Se Hoon
    Su, Wen-Pin
    Parmar, Hema
    Guan, Xuesong
    Gorla, Seema Rao
    Homet Moreno, Blanca
    Valderrama, Begona Perez
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : LBA530 - LBA530
  • [43] First-line platinum-based chemotherapy and survival outcomes in locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma
    Lin, Zuan
    Fu, Sha
    Zhou, Yixin
    Zhang, Xuanye
    Chen, Chen
    He, Li-na
    Li, Haifeng
    Wang, Yuhong
    Chen, Tao
    Zhang, Li
    Hong, Shaodong
    LUNG CANCER, 2019, 137 : 100 - 107
  • [44] Quality of life, functioning, and symptoms in patients with previously treated locally advanced or metastatic urothelial carcinoma from EV-301: A randomized phase 3 trial of enfortumab vedotin versus chemotherapy.
    Mamtani, Ronac
    Rosenberg, Jonathan E.
    Powles, Thomas
    Sonpavde, Guru P.
    Loriot, Yohann
    Duran, Ignacio
    Lee, Jae-Lyun
    Matsubara, Nobuaki
    Vulsteke, Christof
    Castellano, Daniel
    Sridhar, Srikala S.
    Pappot, Helle
    Valderrama, Begona P.
    Gurney, Howard
    Bedke, Jens
    Van der Heijden, Michiel Simon
    Wu, Chunzhang
    Hepp, Zsolt
    McKay, Caroline
    Petrylak, Daniel P.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [45] Development and Validation of a Nomogram for the Estimation of Response to Platinum-Based Neoadjuvant Chemotherapy in Patients with Locally Advanced Cervical Cancer
    Chen, Wei
    Wang, Bo
    Zeng, Rong
    Wang, Tiejun
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 1279 - 1289
  • [46] Fibroblast Growth Factor Receptor 3 Alteration Status is Associated with Differential Sensitivity to Platinum-based Chemotherapy in Locally Advanced and Metastatic Urothelial Carcinoma
    Teo, Min Yuen
    Mota, Jose Mauricio
    Whiting, Karissa A.
    Li, Han A.
    Funt, Samuel A.
    Lee, Chung-Han
    Solit, David B.
    Al-Ahmadie, Hikmat
    Milowsky, Matthew, I
    Balar, Arjun, V
    Pietzak, Eugene
    Dalbagni, Guido
    Bochner, Bernard H.
    Ostrovnaya, Irina
    Bajorin, Dean F.
    Rosenberg, Jonathan E.
    Iyer, Gopa
    EUROPEAN UROLOGY, 2020, 78 (06) : 907 - 915
  • [47] Efficacy and Tolerability of Tremelimumab in Locally Advanced or Metastatic Urothelial Carcinoma Patients Who Have Failed First-Line Platinum-Based Chemotherapy
    Sharma, Padmanee
    Sohn, Joohyuk
    Shin, Sang Joon
    Oh, Do-Youn
    Keam, Bhumsuk
    Lee, Hyo Jin
    Gizzi, Marco
    Kalinka, Ewa
    de Vos, Filip Y. F. L.
    Ruscica, Dario
    Ferro, Salvatore
    Xiao, Feng
    Baverel, Paul
    Chen, Cecil Chi-Keung
    Asubonteng, Kobby
    Morsli, Nassim
    Dirix, Luc
    CLINICAL CANCER RESEARCH, 2020, 26 (01) : 61 - 70
  • [48] Match-adjusted indirect comparison of durvalumab and chemotherapy for locally advanced or metastatic urothelial carcinoma (UC) following failure of platinum-based therapy
    Hoyle, C. K.
    Klein, A. B.
    Patel, K. A.
    Shire, N.
    Wang, H.
    Chu, B. C.
    Ouwens, M.
    Nordstrom, B. L.
    Horne, L.
    Arkenau, H-T.
    ANNALS OF ONCOLOGY, 2018, 29 : 323 - 323
  • [49] Enfortumab vedotin (EV) with pembrolizumab (P) versus chemotherapy (chemo) in previously untreated locally advanced or metastatic urothelial carcinoma (la/mUC): Analysis of cisplatin (cis)-eligible population from EV-302/KEYNOTE-A39
    Bedke, Jens
    Van Der Heijden, Michiel Simon
    Powles, Thomas
    Valderrama, Begona Perez
    Kikuchi, Eiji
    Iyer, Gopa
    Vulsteke, Christof
    Swami, Umang
    Castellano, Daniel
    Sarwar, Naveed
    Drakaki, Alexandra
    Hoffman-Censits, Jean H.
    Arafat, Waddah
    Andabekov, Timur
    Li, Jian-Ri
    Lu, Yi-Tsung
    Yu, Xuesong
    Shetty, Aditya
    Moreno, Blanca Homet
    Gupta, Shilpa
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [50] Response of Patients with advanced Urothelial Cancer to Treatment with Vinflunine after prior platinum-based Chemotherapy: What Influences does the Tumor Location make?
    Hegele, A.
    de Geeter, P.
    Goebell, P. J.
    Matz, U.
    de Schultz, W.
    Edlich, B.
    Retz, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 85 - 85
12345